Upper gastrointestinal toxicity of rofecoxib and naproxen.
Delgado Fernández
M
M
Zambrana García
J L
JL
Diez García
F
F
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D004992:Ethics, Medical; D006471:Gastrointestinal Hemorrhage / Q000517:prevention & control*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D008875:Middle Aged; D016595:Misoprostol / Q000627:therapeutic use; D009288:Naproxen / Q000009:adverse effects*; D054328:Proton Pump Inhibitors; D012307:Risk Factors; D013450:Sulfones
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists; D007783:Lactones; D054328:Proton Pump Inhibitors; D013450:Sulfones; D016595:Misoprostol; C116926:rofecoxib; D009288:Naproxen